Clinical Trials Directory

Trials / Completed

CompletedNCT02003235

Assessment of Device for Treatment of Amblyopia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Visior Technologies Ltd. · Industry
Sex
All
Age
4 Years – 8 Years
Healthy volunteers
Not accepted

Summary

The study will evaluate the effect of Reviview™, a dichoptic video display device for administrating a novel treatment protocol for Amblyopia (lazy eye) in kids. The effect of the treatment will be measured by the change from baseline in Visual acuity and in Stereoscopic Vision; and to assess the ease of use of and compliance by the patients.

Conditions

Interventions

TypeNameDescription
DEVICEDaily watching videos using Reviview™, a dichoptic video display device, for 60 min

Timeline

Start date
2013-10-01
Primary completion
2017-07-15
Completion
2017-07-15
First posted
2013-12-06
Last updated
2017-07-21

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02003235. Inclusion in this directory is not an endorsement.

Assessment of Device for Treatment of Amblyopia (NCT02003235) · Clinical Trials Directory